Navigation Links
Techne Corporation Declares Dividend
Date:10/23/2008

MINNEAPOLIS, Oct. 23 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH) announced today that its Board of Directors has decided to pay a dividend of $0.25 per share for the quarter ended September 30, 2008. The quarterly dividend will be payable November 17, 2008 to all common shareholders of record on November 3, 2008.

Thomas E. Oland, Techne Corporation's Chairman and Chief Executive Officer, said, "I am very pleased to announce that the Board has decided to pay this dividend. As a result of the Company's solid performance, approximately $300 million of cash and available-for-sale investments and strong balance sheet, the Board believes that it is appropriate to provide our shareholders with a cash return on their investment in the Company. Our current cash and available-for-sale investments combined with substantial quarterly cash generation provides us the financial flexibility to further invest in and grow our business while returning value to our shareholders through selective share repurchases and the possibility of future cash dividends."

Techne Corporation has two operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England. R&D Systems is a specialty manufacturer of biological products. R&D Systems has two subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China. BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits. R&D China and R&D Europe distribute biotechnology products.


'/>"/>
SOURCE Techne Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Techne Corporation Announces Share Repurchase Authorization
2. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
3. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2008
4. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
5. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
6. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
9. BioElectronics Corporation Announces Singapore and Malaysia Sales
10. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
11. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... The Houston Technology Center ... its 9th annual gala, "A Celebration of ... that have made a significant impact on the ... The Houston Technology Center named Beth ... year,s honoree. As the Founder and CEO of TechTrans ...
(Date:5/21/2012)... -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Richard ... World Stem Cells & Regenerative Medicine Congress in ... at 12:30 PM. Mr. Garr,s presentation, "Stem Cell ... therapy trial in ALS, its neurogenic small molecule ... an overview on plans to expand the cellular ...
(Date:5/18/2012)...  Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that ... CEO, will be presenting at the Seventh Annual ... (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) The title ... Offer Attractive Targets for Active and Passive Immunotherapy." ... at the Intercontinental Hotel in Boston from 10:15-11:30 ...
(Date:5/17/2012)... -- The " Anesthesia Drugs Market ... analyzes and studies the U.S. market for intravenous anesthesia drugs ... U.S., potential buyers, export & import system for controlled substances in ... market data tables and in-depth TOC of   " ...   U.S. Market Entry Study ...
Breaking Biology Technology:Leading Technology Incubator Honors Extraordinary Entrepreneurs 2Leading Technology Incubator Honors Extraordinary Entrepreneurs 3Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 2Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 3
... Promises Active Role in Community...promotes entertainment everywhere on any ... Wednesday shareholder approval for the sale of the companys ... Pictures Digital. (SPD) The transaction is now complete and ... stated that it will keep the companys employee base ...
... , ,Madison, WI - WE Energies announced Monday a ... will build three wind farms increasing the total amount ... ,Under the agreement, the two developers, Navitas Energy, based ... Chicago, will provide their entire energy output from the ...
... they will come is an acceptable strategy if voices are ... Iowa cornfield, but its not normally the way medical research ... in place, the La Crosse Health Science Center may yet ... Dreams. , ,The $27 million, 168,000-square-foot center is already an ...
Other Biology Technology:Sony Completes Acquisition of Sonic Foundry 2Sony Completes Acquisition of Sonic Foundry 3WE Energies Is Not Letting Wind Power Blow Away 2La Crosse Health Science Center is an Evolving Example of Collaboration 2La Crosse Health Science Center is an Evolving Example of Collaboration 3
(Date:5/21/2012)... A tool commonly used by financial strategists to determine ... portfolio was used to develop a diversified portfolio of ... conservation purposes given the uncertainty about climate change. , ... the history of a stock, University of Illinois environmental ... the historical climate data of the Prairie Pothole Region ...
(Date:5/21/2012)... SEATTLE, May 21, 2012 Researchers from Seattle Biomedical ... the University of Edinburgh have uncovered new knowledge related ... parasites are able to bind to cells in the ... form of the disease. Three related papers will be ... ( Proceedings of the National Academy of Sciences ), ...
(Date:5/21/2012)...  Chiltern International Limited (Chiltern), a global contract ... recognized with a CRO Leadership Award in all ... The awards are given by Life Science Leader ... Insight. Glenn Kerkhof , ... recognized as a CRO leader in the Quality, ...
Breaking Biology News(10 mins):Financial tool considered climate change uncertainty to select land for conservation 2Financial tool considered climate change uncertainty to select land for conservation 3New discoveries about severe malaria 2Chiltern Wins CRO Leadership Award From Life Science Leader 2Medication Telemonitoring Improves Compliance and Behavior in NIH Study 14209 1Medication Telemonitoring Improves Compliance and Behavior in NIH Study 14209 2Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 1Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 2Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 3Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 4Osseon Signs International Distribution Agreement With MBA Incorporado 57980 1Osseon Signs International Distribution Agreement With MBA Incorporado 57980 2Osseon Signs International Distribution Agreement With MBA Incorporado 57980 3
... are veritable canaries in the coal mine, well-recognized ... their presence and abundance in forest landscapes. So ... that the USDA Forest Services Forest Inventory and ... symbiotic organisms as part of its periodic nationwide ...
... Reston, Va.The extraordinary action of a new cellular therapy ... and SPECT imaging in a recent study reported in ... Researchers in Germany were able to observe the repair ... capable of developing into adult stem cells, as they ...
... animal and human studies that genistein, a potent chemical found ... only if consumed during puberty, says a Georgetown University Medical ... today. The challenge now, she says, is for scientists ... against the most common cancer in women. , ...
Other Biology News:Power of molecular imaging reveals secrets of the heart 2Evidence now suggests eating soy foods in puberty protects against breast cancer 2Evidence now suggests eating soy foods in puberty protects against breast cancer 3
Anti-DAP-1, Rabbit Monoclonal Immunogen: KLH-conjugated synthetic peptide corresponding to the C-terminal region of human DAP-1. Molecular Weight: 11 kDa Quality Assurance: Routinely eval...
Wnt-1 (G-19)...
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
Myt 1 (N-17)...
Biology Products: